Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
Mathioudakis, Alexander G.; Abroug, Fekri; Agusti, Alvar; Bakke, Per; Bartziokas, Konstantinos; Beghe, Bianca; Bikov, Andras; Bradbury, Thomas; Brusselle, Guy; Cadus, Cordula; Coleman, Courtney; Contoli, Marco; Corlăteanu, Alexandru; Corlăteanu, Olga; Criner, Gerard; Csoma, Balazs; Emelyanov, Alexander; Faner, Rosa; Romero, Gustavo Fernandez; Hammouda, Zeineb; Horváth, Peter; Huerta, Arturo Garcia; Jacobs, Michael; Jenkins, Christine; Joos, Guy; Kharevich, Olga; Kostikas, Konstantinos; Lapteva, Elena; Lazar, Zsofia; Leuppi, Joerg D.; Liddle, Carol; López-Giraldo, Alejandra; McDonald, Vanessa M.; Nielsen, Rune; Papi, Alberto; Saraiva, Isabel; Sergeeva, Galina; Sioutkou, Agni; Sivapalan, Pradeesh; Stovold, Elizabeth; Wang, Hao; Wen, Fuqiang; Yorke, Janelle; Williamson, Paula R.; Vestbo, Jørgen; Jensen, Jens-Ulrik
Date:
2020
Abstract:
Randomised controlled trials (RCTs) on the management of COPD exacerbations evaluate
heterogeneous outcomes, often omitting those that are clinically important and patient relevant. This limits their
usability and comparability. A core outcome set (COS) is a consensus-based minimum set of clinically
important outcomes that should be evaluated in all RCTs in specific areas of health care. We present the study
protocol of the COS-AECOPD ERS Task Force, aiming to develop a COS for COPD exacerbation management,
that could remedy these limitations.
For the development of this COS we follow standard methodology recommended by the COMET initiative.
A comprehensive list of outcomes is assembled through a methodological systematic review of the outcomes
reported in relevant RCTs. Qualitative research with patients with COPD will also be conducted, aiming to
identify additional outcomes that may be important to patients, but are not currently addressed in clinical
research studies. Prioritisation of the core outcomes will be facilitated through an extensive, multi-stakeholder
Delphi survey with a global reach. Selection will be finalised in an international, multi-stakeholder meeting. For
every core outcome, we will recommend a specific measurement instrument and standardised time points for
evaluation. Selection of instruments will be based on evidence-informed consensus.
Our work will improve the quality, usability and comparability of future RCTs on the management of COPD
exacerbations and, ultimately, the care of patients with COPD. Multi-stakeholder engagement and societal
support by the European Respiratory Society will raise awareness and promote implementation of the COS.
Show full item record